Stem Cell and Regenerative Medicine in Missouri: What’s Legal and What to Know

Last reviewed: [5/2026 · Verify current state guidance before relying on any specific claim

Missouri occupies a historically significant place in American stem cell policy: in November 2006, it became the first U.S. state to constitutionally protect stem cell research via a citizen-initiated ballot amendment. Missouri Constitutional Amendment 2 — formally the Missouri Stem Cell Research and Cures Initiative — passed with 51% of the vote and is codified at Missouri Constitution Article III, Section 38(d). The amendment authorizes any stem cell research and therapy that is legal under federal law (including somatic cell nuclear transfer to produce human embryos for stem cell production), while prohibiting reproductive human cloning. Missouri also adopted a Right to Try law. The state hosts one of the country’s premier biomedical research institutions in Washington University in St. Louis. The Missouri Board of Registration for the Healing Arts regulates physicians.

For the federal framework that applies in every state — FDA regulation of cell and tissue products under 21 CFR Part 1271, the 361/351 distinction, FDA enforcement history, and the federal Right to Try Act — see How Regenerative Medicine Is Regulated in the United States.

Missouri Constitutional Amendment 2 (2006)

The Missouri Stem Cell Research and Cures Initiative — known as Amendment 2 — appeared on the November 2006 general election ballot and passed with approximately 51% of the vote (Missouri Amendment 2 — Ballotpedia). Missouri was the first state in the United States to pass a state constitutional amendment specifically protecting stem cell research.

The amendment is codified at Missouri Constitution Article III, Section 38(d) (Missouri Revisor of Statutes — Article III Section 38(d)).

Key provisions:

  • Missouri citizens and patients have a constitutional right to access stem cell research and therapies that are legal under federal law.
  • Somatic cell nuclear transfer (SCNT) to produce human embryos for stem cell production is permitted.
  • Reproductive human cloning is prohibited.
  • Research must comply with general state laws of general applicability, including those related to scientific and medical practice, patient safety, and ethical review.

Background on the initiative’s politics and ethical debate: Missouri stem cells amendment protects fundamental rights (JURIST); Wikipedia: 2006 Missouri Amendment 2.

The 2006 amendment has remained politically active in subsequent legislative sessions, with periodic attempts to limit public funding for stem cell research (Columbia Missourian: prohibition of public funding for abortion, cloning, stem cell research heard in Senate). The underlying constitutional protection remains in place.

Missouri’s Right to Try Law

Missouri adopted Right to Try legislation [VERIFY exact year — Missouri was among the early-adopter group, commonly cited as 2014 or 2015 session, codified within Missouri Revised Statutes]. The Missouri law operates in parallel with the federal Right to Try Act of 2018 and allows eligible patients with terminal illnesses to access investigational drugs, biological products, and devices that have completed FDA Phase 1 clinical trials.

The Missouri statute does not authorize clinics to offer unapproved stem cell, exosome, or peptide therapies outside the narrow conditions of the Act — terminal diagnosis, exhausted FDA-approved options, physician recommendation, access through the actual sponsor of an investigational product.

The Missouri Board of Registration for the Healing Arts

The Missouri Board of Registration for the Healing Arts, within the Missouri Division of Professional Registration, licenses and regulates allopathic and osteopathic physicians, physician assistants, and several allied practitioner categories. The Board operates under Missouri Revised Statutes Chapter 334.

As of late 2025 [VERIFY current Board publications], the Board has not issued a comprehensive standalone policy on commercial stem cell, PRP, NAD+, or peptide therapy. Standard practice-of-medicine rules apply.

Missouri’s Regenerative Medicine Research Activity

Missouri hosts some of the country’s most influential biomedical research:

  • Washington University in St. Louis School of Medicine — one of the country’s top research-active medical schools. The Stem Cell Biology Program, the Genome Institute, and the Center of Regenerative Medicine run extensive basic, translational, and clinical research.
  • Siteman Cancer Center (Washington University and Barnes-Jewish Hospital) — hematologic cell therapy and CAR-T programs.
  • University of Missouri School of Medicine (Columbia) — translational research and clinical trials.
  • Stowers Institute for Medical Research (Kansas City) — independent non-profit research institute with stem cell biology programs.
  • St. Louis University — affiliated cancer and translational research programs.

Missouri’s research footprint is partly a legacy of the political environment created by Amendment 2 — the 2006 constitutional protection has supported continued investment in regenerative medicine programs in St. Louis and beyond.

Patients in Missouri with an interest in legitimate experimental access should search clinicaltrials.gov for active trials at these institutions before considering cash-pay options at commercial clinics.

IV Therapy and NAD+ in Missouri

NAD+ intravenous therapy is broadly available in Missouri. Registered nurses may administer IV under physician orders. Missouri’s APRN scope-of-practice framework allows nurse practitioners to prescribe and supervise IV therapy within their scope (subject to specific collaborative agreement requirements). IV lounges, mobile IV services, and concierge IV providers operate in St. Louis, Kansas City, Springfield, Columbia, and other metros.

NAD+ itself is compounded through 503A or 503B pharmacies and is not FDA-approved for any indication. Patients pay out of pocket.

Telemedicine and Out-of-State Providers

Missouri is a member of the Interstate Medical Licensure Compact. Missouri residents can establish telehealth relationships with out-of-state physicians licensed through the compact.

Notable Enforcement

The FDA’s public Warning Letter database is the authoritative source for federal enforcement against specific Missouri-based clinics [VERIFY against current list]. The 2021 federal injunction in United States v. US Stem Cell Clinic, LLC applies in Missouri as in every state.

Missouri has not been a notable focus of state attorney general action against the commercial regenerative medicine sector.

Cost and Clinic Landscape

Regenerative medicine clinics in Missouri cluster in the St. Louis metropolitan area, Kansas City, Springfield, and Columbia. Celmedica currently lists [X] verified clinics across Missouri — pull live count.

Typical out-of-pocket pricing in Missouri (representative ranges; individual clinics vary):

  • PRP joint injection: $450 – $1,200 per session
  • Autologous stem cell injection (single joint or area): $4,500 – $9,000
  • NAD+ IV (single drip): $375 – $800
  • Peptide protocols: $200 – $1,200 per month, varies by compound

Insurance generally does not cover regenerative therapies. Some orthopedic indications for PRP are occasionally covered.

Clinical-trial participation at Washington University, the Siteman Cancer Center, and University of Missouri is sometimes available and meaningfully cheaper or free.

Frequently Asked Questions

Is stem cell therapy legal in Missouri? Missouri has a constitutional amendment (Article III, Section 38(d)) protecting stem cell research and therapy that is legal under federal law. Commercial stem cell therapy operates under federal FDA rules and Missouri Board of Registration for the Healing Arts practice standards.

What did Missouri Amendment 2 actually do? Passed by voters in November 2006, Amendment 2 added Article III, Section 38(d) to the Missouri Constitution. It guarantees Missouri patients and researchers the right to access stem cell research and therapy that is legal under federal law, permits somatic cell nuclear transfer to produce embryos for stem cell research, and prohibits reproductive human cloning. Missouri was the first state to constitutionally protect stem cell research by voter initiative.

Does Missouri’s Right to Try law cover stem cell therapy? Only in the narrow case of investigational stem cell products that have completed FDA Phase 1 trials, for a patient with a terminal illness, accessed through the actual product sponsor. The law does not authorize a clinic to offer unapproved stem cell therapy as a routine cash-pay service.

Can I access stem cell clinical trials at Washington University in St. Louis? Washington University and the Siteman Cancer Center run substantial cell-therapy and stem cell research portfolios. Many trials actively enroll. Searchable at clinicaltrials.gov.

How much does stem cell therapy cost in Missouri? Autologous stem cell injections for a single joint typically range $4,500–$9,000 in Missouri metros. PRP runs $450–$1,200. Clinical-trial participation at Washington University, Siteman, or the University of Missouri is sometimes available and substantially cheaper or free.

Bottom Line

Missouri has both an unusually strong constitutional protection for stem cell research (the 2006 Amendment 2) and one of the country’s most productive academic medical research environments (Washington University in St. Louis). For commercial stem cell therapy, the federal framework dominates; Missouri’s constitutional amendment matters most for research and embryonic-origin work, while Right to Try and Board practice rules govern day-to-day clinical practice. Patients should focus on physician credentials, FDA product classification of the specific therapy, and whether clinical-trial access at Washington University, Siteman, or the University of Missouri is available before considering cash-pay options.

Next steps:

[FTC affiliate disclosure block]: Some links in this guide may earn Celmedica a commission at no additional cost to you. Read our affiliate disclosure.

[Medical disclaimer]: This guide is for informational purposes and does not constitute legal or medical advice. State laws and regulatory guidance change. Verify current rules with the Missouri Board of Registration for the Healing Arts and the FDA, and consult a qualified physician before pursuing any therapy.

References

For the federal regulatory citations, see the federal baseline references.

Missouri-specific: